Paul Naaber

5.3k total citations · 2 hit papers
56 papers, 2.5k citations indexed

About

Paul Naaber is a scholar working on Infectious Diseases, Epidemiology and Molecular Biology. According to data from OpenAlex, Paul Naaber has authored 56 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Infectious Diseases, 16 papers in Epidemiology and 12 papers in Molecular Biology. Recurrent topics in Paul Naaber's work include Antibiotic Resistance in Bacteria (12 papers), Clostridium difficile and Clostridium perfringens research (11 papers) and SARS-CoV-2 and COVID-19 Research (9 papers). Paul Naaber is often cited by papers focused on Antibiotic Resistance in Bacteria (12 papers), Clostridium difficile and Clostridium perfringens research (11 papers) and SARS-CoV-2 and COVID-19 Research (9 papers). Paul Naaber collaborates with scholars based in Estonia, Norway and Sweden. Paul Naaber's co-authors include Björkstén, Marika Mikelsaar, Epp Sepp, Bengt Björkstén, Siiri Kõljalg, Maire Vasar, Kaja Julge, Raik-Hiio Mikelsaar, Pärt Peterson and Kai Kisand and has published in prestigious journals such as PLoS ONE, Clinical Infectious Diseases and Journal of Clinical Microbiology.

In The Last Decade

Paul Naaber

53 papers receiving 2.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The intestinal microflora in allergic Estonian and Swedish 2‐year‐old children

1999 690 citations Paul Naaber et al. profile →
Dynamics of antibody response to BNT162b2 vaccine after six months: a longitudinal prospective study

2021 379 citations Paul Naaber, Liina Tserel et al. The Lancet Regional Health - Europe profile →

Peers

Paul Naaber

PHYSI

EPIDE

Epp Sepp Estonia

Bianca E.P. Snijders Netherlands

Lisa Thorson Canada

Ingegerd Adlerberth Sweden

Anders Pærregaard Denmark

Sören Gatermann Germany

Mikael Kuitunen Finland

Carl Vael Belgium

Heikki Arvilommi Finland

Shira Doron United States

Epp Sepp Estonia

Paul Naaber

729 ×0.8

1.1k ×1.6

781 ×1.5

617 ×1.3

PHYSI

300 ×1.0

EPIDE

Citations per year, relative to Paul Naaber Paul Naaber (= 1×) peers Epp Sepp

Countries citing papers authored by Paul Naaber

Since Specialization

Citations

This map shows the geographic impact of Paul Naaber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Naaber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Naaber more than expected).

Fields of papers citing papers by Paul Naaber

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul Naaber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Naaber. The network helps show where Paul Naaber may publish in the future.

Co-authorship network of co-authors of Paul Naaber

This figure shows the co-authorship network connecting the top 25 collaborators of Paul Naaber. A scholar is included among the top collaborators of Paul Naaber based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul Naaber. Paul Naaber is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Soeorg, Hiie, Aare Abroi, Paul Naaber, et al.. (2024). Dynamics of SARS-CoV-2 lineages in children and adults in 2021 and 2022. PLoS ONE. 19(12). e0316213–e0316213.

Pärna, Kersti, Mari Nygård, Karolin Toompere, et al.. (2023). Age-specific and genotype-specific carcinogenic human papillomavirus prevalence in a country with a high cervical cancer burden: results of a cross-sectional study in Estonia. BMJ Open. 13(6). e069558–e069558. 2 indexed citations

Naaber, Paul, Liina Tserel, Kadri Kangro, et al.. (2021). Dynamics of antibody response to BNT162b2 vaccine after six months: a longitudinal prospective study. The Lancet Regional Health - Europe. 10. 100208–100208. 379 indexed citations breakdown →

Soeorg, Hiie, Freddy Lättekivi, Paul Naaber, et al.. (2021). Prevalence of SARS-CoV-2 IgG antibodies and their association with clinical symptoms of COVID-19 in Estonia (KoroSero-EST-1 study). Vaccine. 39(38). 5376–5384. 7 indexed citations

Naaber, Paul, Liis Haljasmägi, Pauliina Rumm, et al.. (2020). Evaluation of SARS-CoV-2 IgG antibody response in PCR positive patients: Comparison of nine tests in relation to clinical data. PLoS ONE. 15(10). e0237548–e0237548. 26 indexed citations

Sepp, Epp, Reidar Andreson, Arta Balode, et al.. (2019). Phenotypic and Molecular Epidemiology of ESBL-, AmpC-, and Carbapenemase-Producing Escherichia coli in Northern and Eastern Europe. Frontiers in Microbiology. 10. 2465–2465. 28 indexed citations

Kõljalg, Siiri, Epp Sepp, Imbi Smidt, et al.. (2017). A combination of the probiotic and prebiotic product can prevent the germination of Clostridium difficile spores and infection. Anaerobe. 47. 94–103. 35 indexed citations

Mitt, Piret, Tuuli Metsvaht, Kaidi Telling, et al.. (2013). Five-year prospective surveillance of nosocomial bloodstream infections in an Estonian paediatric intensive care unit. Journal of Hospital Infection. 86(2). 95–99. 18 indexed citations

Sepp, Epp, Jelena Štšepetova, Imbi Smidt, et al.. (2011). Intestinal lactoflora in Estonian and Norwegian patients with antibiotic associated diarrhea. Anaerobe. 17(6). 407–409. 12 indexed citations

10.

Sepp, Epp, Jelena Štšepetova, Krista Lõivukene, et al.. (2009). The occurrence of antimicrobial resistance and class 1 integrons among commensal Escherichia coli isolates from infants and elderly persons. Annals of Clinical Microbiology and Antimicrobials. 8(1). 34–34. 19 indexed citations

11.

Hanberger, Håkan, Dilek Arman, Hans Gill, et al.. (2008). Surveillance of microbial resistance in European Intensive Care Units: a first report from the Care-ICU programme for improved infection control. Intensive Care Medicine. 35(1). 91–100. 81 indexed citations

12.

Tamm, Eda, Paul Naaber, Matti Maimets, et al.. (2007). Antimicrobial susceptibility and serogroup/serotype distribution of nasopharyngeal isolates of Streptococcus pneumoniae in healthy Estonian children in 1999–2003. Clinical Microbiology and Infection. 13(8). 824–826. 7 indexed citations

13.

Lõivukene, Krista, et al.. (2006). Surveillance de la résistance aux antibiotiques des pathogènes invasifs : l’expérience de l’Estonie. Eurosurveillance. 11(2). 9–10. 2 indexed citations

14.

Naaber, Paul, Anneli Uusküla, Airi Põder, et al.. (2005). Laboratory Diagnosis of Sexually Transmitted Infections in Estonia in 2001–2002: Shortcomings With Impact on Diagnostic Quality and Surveillance. Sexually Transmitted Diseases. 32(12). 759–764. 13 indexed citations

15.

Naaber, Paul & Marika Mikelsaar. (2004). Interactions between Lactobacilli and Antibiotic-Associated Diarrhea. Advances in applied microbiology. 54. 231–260. 20 indexed citations

16.

Järv, H., et al.. (2004). Toenail onychomycosis in Estonia. Mycoses. 47(1-2). 57–61. 29 indexed citations

17.

Lõivukene, Krista & Paul Naaber. (2003). Antibiotic susceptibility of clinically relevant anaerobes in Estonia from 1999 to 2001. Anaerobe. 9(2). 57–61. 14 indexed citations

18.

Kõljalg, Siiri, Paul Naaber, & Marika Mikelsaar. (2002). Antibiotic resistance as an indicator of bacterial chlorhexidine susceptibility. Journal of Hospital Infection. 51(2). 106–113. 84 indexed citations

19.

Naaber, Paul, Siiri Kõljalg, & Matti Maimets. (2000). Antibiotic usage and resistance — trends in Estonian University Hospitals. International Journal of Antimicrobial Agents. 16(3). 309–315. 19 indexed citations

20.

Naaber, Paul, et al.. (1996). Inhibition of adhesion ofClostridium difficileto Caco-2 cells. FEMS Immunology & Medical Microbiology. 14(4). 205–209. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact